SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rolf Schoch who wrote ()3/6/2000 9:12:00 PM
From: scott_jiminez  Read Replies (1) of 4474
 
Here's how today's action was characterized on Bloomberg (verbatim):

Ariad (ARIA) fell 6 7/16, or 15 percent, to 36 1/16. The shares more than doubled last week after the company announced it had developed a class of small-molecule drugs that inhibit the breakdown of bone resulting in osteoporosis. The company also had reported a fourth-quarter profit from operations of $1.59 a share, after a loss of 32 cents a year earlier.

In short, a normal retracement subsequent to a dizzying rally.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News